CorMedix CRMD
$5.27 +$0.19 (+3.74%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $5.32 +0.95%
Open$4.96
Prev close$5.08
Day range$4.95 – $5.32
Volume3.61M
Market cap$419.16M
P/E (TTM)8.2
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$51.26M-50.8% YoY
Operating profit-$6.62M-112.9% YoY
Net profit-$14.72M-113.6% YoY
Diluted EPS-$0.19-115.1% YoY
Free cash flow$87.79M+189.2% YoY
Operating cash flow$89.70M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin77.0%
Operating margin39.4%
Net margin15.6%
Return on equity15.1%
Return on assets7.5%
Return on invested capital11.1%
Current ratio2.43
Liabilities / assets49.7%
Cash & investments$355.15M
Total debt$145.42M
Net cash (debt)$209.73M
Free cash flow / sales76.2%
Where the revenue comes from
Quarter 2026/Q2
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $54.52M | – | $127.43M | $311.71M | $128.62M |
| Total Operating Revenue | $51.26M | $99.31M | $127.43M | $311.71M | $128.62M |
| Cost of Revenue | $24.52M | $24.81M | $22.31M | $35.96M | $21.31M |
| Gross Profit | $26.75M | $74.50M | $105.12M | $275.75M | $107.31M |
| Operating Expense | $33.37M | $31.59M | $41.46M | $125.61M | $48.18M |
| Selling and Admin Expenses | $29.59M | $27.53M | $34.25M | $106.27M | $39.58M |
| -Selling & Marketing Expense | $11.68M | $12.45M | $12.53M | $38.05M | $16.01M |
| -General & Admin Expense | $17.90M | $15.09M | $21.72M | $68.22M | $23.57M |
| Research & Development | $7.04M | $6.68M | $7.21M | $19.33M | $8.60M |
| Other Operating Expenses | -$3.26M | -$2.62M | – | – | – |
| Operating Profit | -$6.62M | $42.91M | $63.66M | $150.14M | $59.13M |
| Other Income (Expense) | -$9.83M | -$4.18M | -$8.01M | -$1.19M | -$3.74M |
| Gain on Sale of Security | $1.18M | $2.55M | -$3.55M | $5.31M | $2.22M |
| Special Income (Charges) | -$11.54M | -$6.65M | -$4.20M | -$6.50M | -$4.10M |
| -Less:Restructuring and Mergern & Acquisition | $11.54M | $6.65M | $4.20M | $6.50M | $4.10M |
| Other Non-Operating Income (Expenses) | $532,000.00 | -$71,000.00 | -$268,000.00 | – | – |
| Pretax Profit | -$16.45M | $38.73M | $55.65M | $150.02M | $56.45M |
| Tax | -$1.73M | $12.75M | $17.04M | -$13.04M | $42.43M |
| Net Profit | -$14.72M | $25.99M | $38.60M | $163.06M | $14.02M |
| Profit from Continuing Operations | -$14.72M | $25.99M | $38.60M | $163.06M | $14.02M |
| Net Income to Parent Company | -$14.72M | $25.99M | $38.60M | $163.06M | $14.02M |
| Net Income to Common Stockholders | -$14.72M | $25.99M | $38.36M | $162.07M | $13.03M |
| Basic EPS | -$0.19 | $0.33 | $0.48 | $2.25 | $0.18 |
| Diluted EPS | -$0.19 | $0.29 | $0.43 | $2.04 | $0.16 |
| Other Preferred Stock Dividends | – | – | $241,000.00 | $988,000.00 | – |
| Net Non-Operating Interest Income (Expense) | – | – | – | $1.06M | -$927,098.00 |
| Non-Operating Interest Income | – | – | – | $3.85M | $889,981.00 |
| Non-Operating Interest Expense | – | – | – | $2.78M | $1.82M |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $917.75M | $904.05M | $815.64M | $826.14M | $826.14M |
| Total Current Assets | $502.99M | $480.55M | $383.11M | $367.05M | $367.05M |
| Cash and Cash Equivalents & Short-Term Investments | $355.15M | $256.69M | $178.09M | $148.53M | $148.53M |
| -Cash and Cash Equivalents | $355.15M | $256.69M | $178.09M | $144.84M | $144.84M |
| -Short Term Investments | $0.00 | $0.00 | $0.00 | $3.69M | $3.69M |
| Receivables | $76.71M | $161.31M | $154.81M | $171.23M | $171.23M |
| -Accounts Receivable | $76.71M | $161.31M | $154.81M | $171.23M | $171.23M |
| Inventory | $43.14M | $38.58M | $30.73M | $29.72M | $29.72M |
| Restricted Cash | $656,000.00 | $656,000.00 | $656,000.00 | $656,000.00 | $656,000.00 |
| Other Current Assets | $27.34M | $23.32M | $18.83M | $7.86M | $7.86M |
| Total Non-Current Assets | $414.75M | $423.50M | $432.52M | $459.09M | $459.09M |
| Net PPE | $8.56M | $7.85M | $6.17M | $8.98M | $8.98M |
| -Gross PPE | $8.56M | $7.85M | $6.17M | $8.98M | $8.98M |
| Goodwill and Other Intangible Assets | $378.17M | $388.47M | $398.77M | $409.07M | $409.07M |
| -Goodwill | $30.00M | $30.00M | $30.00M | $30.00M | $30.00M |
| -Other Intangible Assets | $348.17M | $358.47M | $368.77M | $379.07M | $379.07M |
| Non-Current Deferred Assets | $0.00 | $0.00 | $3.31M | $16.28M | $16.28M |
| Other Non-Current Assets | $28.02M | $27.17M | $24.27M | $423,000.00 | $423,000.00 |
| Total Liabilities | $456.04M | $443.22M | $378.59M | $420.84M | $420.84M |
| Total Current Liabilities | $207.29M | $187.40M | $128.78M | $174.27M | $174.27M |
| Payables | $16.15M | $23.29M | $29.67M | $21.45M | $21.45M |
| -Accounts Payable | $10.33M | $10.24M | $12.83M | $7.88M | $7.88M |
| -Total Tax Payable | $5.82M | $13.05M | $16.84M | $12.76M | $12.76M |
| Current Accrued Expenses | $159.76M | $153.17M | $91.30M | $146.07M | $146.07M |
| Other Current Liabilities | $31.38M | $10.94M | $7.81M | $5.31M | $5.31M |
| Total Non-Current Liabilities | $248.75M | $255.82M | $249.81M | $246.57M | $246.57M |
| Long Term Debt and Capital Lease Obligation | $145.42M | $145.15M | $144.89M | $147.47M | $147.47M |
| -Long Term Debt | $145.42M | $145.15M | $144.89M | $144.63M | $144.63M |
| Non-Current Deferred Liabilities | $2.19M | $663,000.00 | – | – | – |
| Other Non-Current Liabilities | $101.14M | $110.01M | $104.93M | $99.10M | $99.10M |
| Total Equity | $461.71M | $460.83M | $437.05M | $405.31M | $405.31M |
| Stockholders' Equity | $461.71M | $460.83M | $437.05M | $405.31M | $405.31M |
| Capital Stock | $79,000.00 | $78,000.00 | $78,000.00 | $79,000.00 | $79,000.00 |
| -Common Stock | $79,000.00 | $78,000.00 | $78,000.00 | $79,000.00 | $79,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $588.33M | $572.74M | $574.94M | $581.80M | $581.80M |
| Retained Earnings | -$126.71M | -$111.99M | -$137.97M | -$176.58M | -$176.58M |
| Gains/Losses Not Affecting Retained Earnings | $2,000.00 | $2,000.00 | $2,000.00 | $3,000.00 | $3,000.00 |
| Prepaid Assets | – | – | – | $9.05M | $9.05M |
| Investments and Advances | – | – | – | $10.36M | $10.36M |
| -Available for Sale Securities | – | – | – | $10.36M | $10.36M |
| Non Current Accounts Receivables | – | – | – | $946,000.00 | $946,000.00 |
| Non-Current Prepaid Assets | – | – | – | $13.03M | $13.03M |
| -Other Payable | – | – | – | $804,000.00 | $804,000.00 |
| Short-Term Debt and Capital Lease Obligation | – | – | – | $1.45M | $1.45M |
| -Current Capital Lease Obligation | – | – | – | $1.45M | $1.45M |
| -Long Term Capital Lease Obligation | – | – | – | $2.84M | $2.84M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $89.70M | $86.24M | $42.38M | $175.05M | $94.46M |
| Net cash flow from continuing operations | $89.70M | $86.24M | $42.38M | $175.05M | $94.46M |
| Net Income from Continuing Operations | -$14.72M | $25.99M | $38.60M | $163.06M | $14.02M |
| Depreciation & Depletion & Amortization | $10.53M | $10.54M | $10.54M | $14.55M | $10.43M |
| Deferred Tax | $1.53M | $3.98M | $12.96M | -$25.80M | $33.89M |
| Other Non-Cash Items | $11.93M | $7.60M | $4.65M | $7.28M | $4.33M |
| Change in Working Capital | $77.69M | $36.60M | -$32.51M | $7.33M | $30.30M |
| -Change in Receivables | $84.75M | -$6.43M | $16.45M | -$90.92M | -$12.40M |
| -Change in Inventory | -$4.56M | -$7.85M | -$1.02M | -$3.48M | -$800,000.00 |
| -Change in Prepaid Assets | -$4.02M | -$5.09M | -$2.26M | -$2.06M | -$1.36M |
| -Change in Payables and Accrued Expense | $1.53M | $56.19M | -$45.68M | $104.10M | $45.01M |
| Net cash flow from investing | -$1.91M | -$561,000.00 | $2.97M | -$308.43M | $3.30M |
| Net Cash Flow from Continuing Investing Activities | -$1.91M | -$561,000.00 | $2.97M | -$308.43M | $3.30M |
| Net PPE Purchase and Sale | -$1.91M | -$561,000.00 | -$729,000.00 | -$2.26M | -$1.72M |
| Net Investment Purchase and Sale | $0.00 | $0.00 | $3.69M | $2.34M | $3.53M |
| Financing Cash Flow | $10.67M | -$7.07M | -$12.10M | $238.45M | -$1.41M |
| Net Cash Flow from Continuing Financing Activities | $10.67M | -$7.07M | -$12.10M | $238.45M | -$1.41M |
| Net Common Stock Issuance | $10.14M | -$6.39M | -$11.09M | $90.16M | $1.03M |
| Proceeds from Stock Option Exercised | $1.79M | $235,000.00 | $1.18M | $6.39M | $3.59M |
| Net Other Financing Charges | -$1.26M | -$914,000.00 | -$2.18M | -$8.09M | -$6.03M |
| Ending Cash Balance | $356.14M | $257.68M | $179.08M | $145.83M | $145.83M |
| Net Change in Cash | $98.46M | $78.61M | $33.25M | $105.07M | $96.35M |
| Beginning Cash Balance | $257.68M | $179.08M | $145.83M | $40.76M | $49.48M |
| Effect of Exchange Rate Changes | $0.00 | $0.00 | $0.00 | $0.00 | -$1,000.00 |
| Free Cash Flow | $87.79M | $85.68M | $41.65M | $172.79M | $92.74M |
| Gain/Loss from Continuing Operations | – | – | – | -$86,000.00 | – |
| -Change in Other Current Liabilities | – | – | – | -$308,000.00 | -$150,000.00 |
| Net Business Purchase and Sale | – | – | – | -$308.51M | $1.49M |
| Net Issuance Payments Of Debt | – | – | – | $150.00M | $0.00 |
No comments yet — be the first to weigh in on CRMD.
Sign in to join the discussion.